Sort by 
Record Exports, Record Ambition: How GLP-1 Medicines Reshaped Ireland’s Pharmaceutical Landscape
Ireland’s pharmaceutical exports hit a record €139 billion in 2025, driven by surging GLP-1 medicine component production. The Goodbody Economic Report for IPHA sets an agenda for sustaining Ireland’s position as the EU’s second-largest pharmaceutical exporter.
Escaping Proof-of-Concept Purgatory: Ireland’s Biopharma Sector Confronts Its Generative AI Challenge
BioPharmaChem Ireland’s Generative AI for Life Sciences Playbook 2025 identifies proof-of-concept purgatory as the defining obstacle to AI adoption across Ireland’s biopharma sector. Over 100 validated use cases map a practical path from experimentation to production-scale value.
ABM Ireland named Gold Sponsor of Life Sciences Industry Awards 2026
ABM Ireland has been announced as Gold Sponsor of the Life Sciences Industry Awards 2026, bringing integrated facility and engineering services expertise to the programme ahead of the awards gala on 28 May at the Crowne Plaza Hotel, Santry. The partnership reflects ABM Ireland's alignment with organisations demonstrating excellence in innovation, operational standards, and sector leadership across Ireland's life sciences industry.
Crystal Pharmatech deploys first dedicated MicroED platform in Asia-Pacific region
China-based pharmaceutical CRO/CDMO Crystal Pharmatech has become the first company in the Asia-Pacific region to deploy a dedicated MicroED platform, advancing industrial-grade solid-state characterisation capabilities for global drug development clients.
Astellas closes Seattle stem cell therapy site in cell and gene therapy consolidation
Japanese pharmaceutical company Astellas is closing its Seattle stem cell therapy site as part of a wider consolidation of its cell, gene therapy, and oncology research operations, affecting approximately 55 employees.
Boehringer Ingelheim opens London AI centre with £150m ten-year investment
German pharmaceutical company Boehringer Ingelheim is launching an artificial intelligence and machine learning centre in London, committing £150 million over ten years to accelerate pharmaceutical research and drug discovery capabilities.
Helus Pharma appoints Eric So as interim chief executive following Michael Cola departure
Clinical-stage pharmaceutical company Helus Pharma has appointed co-founder and Executive Chairman Eric So as Interim Chief Executive Officer following the immediate departure of Michael Cola, while a permanent successor search is under way.
Poolbeg Pharma secures MHRA authorisation for POLB 001 cancer immunotherapy trial
Irish clinical-stage biopharmaceutical company Poolbeg Pharma has received MHRA Clinical Trial Authorisation for its TOPICAL trial, with independent US payer research indicating multi-billion-dollar peak sales potential for lead candidate POLB 001.
From 18th to Front of the Field: Ireland’s Clinical Trials Reform Agenda Takes Shape
Ireland’s National Clinical Trials Oversight Group published a 20-recommendation reform roadmap in November 2025. The report positions Ireland to close the gap with EU peers and attract more pharmaceutical sponsors to Irish research centres.
LEP Biomedical Ltd wins Best Use of Technology Award at the Pharma Industry Awards 2025
Throwing it back to the Pharma Industry Awards 2025, LEP Biomedical Ltd claimed the Best Use of Technology Award for a pioneering application of 3D drug printing that delivered bespoke ocular drug delivery solutions with controllable mechanical properties and precision-managed drug release across multiple parameters. The win set a compelling benchmark for technology-driven pharmaceutical innovation in Ireland, raising the standard of real-world clinical impact and formulation ingenuity that entrants will look to match when the 2026 awards cycle opens.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
